Holen Sie sich die Stockscreener-App
1.01
0.98%
-0.01
Schlusskurs vom Vortag:
$1.02
Offen:
$1.02
24-Stunden-Volumen:
359.77K
Relative Volume:
0.66
Marktkapitalisierung:
$101.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.65M
KGV:
-3.0413
EPS:
-0.3321
Netto-Cashflow:
$-15.84M
1W Leistung:
+4.88%
1M Leistung:
+0.00%
6M Leistung:
-27.86%
1J Leistung:
-23.48%
1-Tages-Spanne:
$1.01
$1.045
1-Wochen-Bereich:
$0.97
$1.08
52-Wochen-Spanne:
$0.7709
$1.59
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Vergleichen Sie CRDL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.01 | 102.00M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
124.02 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.96 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.26 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.64 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
471.01 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-26 | Eingeleitet | ROTH MKM | Buy |
| 2024-04-22 | Eingeleitet | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten
Cardiol Therapeutics announces $13.5M bought-deal private placement - MSN
Will Cardiol Therapeutics Inc. (CT9) stock gain from lower interest ratesChart Pattern Recognition & Free Discover Fast Growing Stocks - bollywoodhelpline.com
Why Cardiol Therapeutics Inc. stock is favored by top institutionsCup and Handle Formations & Identify Breakout Stocks - bollywoodhelpline.com
Portfolio Shifts: Will Cardiol Therapeutics Inc outperform tech stocksTake Profit & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Cardiol Therapeutics announces $13.5 million private placement By Investing.com - Investing.com Nigeria
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics announces $13.5 million bought deal financing By Investing.com - Investing.com Nigeria
Cardiol Therapeutics Inc. announced that it expects to receive CAD 13.500001 million in funding - marketscreener.com
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs - TipRanks
Cardiol Therapeutics announces $13.5 million private placement - Investing.com
Cardiol Therapeutics announces $13.5 million bought deal financing - Investing.com
Heart drug developer Cardiol lines up $13.5M to fund trials and research - Stock Titan
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Yahoo Finance
AI Stocks: Is NeuroSense Therapeutics Ltd Equity Warrant forming a bullish divergenceJuly 2025 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.5% – Still a Buy? - Defense World
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.5%Still a Buy? - MarketBeat
(CRDL) On The My Stocks Page (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives $8.00 Consensus Price Target from Analysts - Defense World
Insider Sell: Is Cardiol Therapeutics Inc stock a safe investment in uncertain markets2025 EndofYear Setup & Consistent Return Strategy Ideas - Bộ Nội Vụ
Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial By Investing.com - Investing.com Nigeria
Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail
Cardiol Therapeutics Reaches 50% Enrollment in Pivotal Phase III MAVERIC Trial for Recurrent Pericarditis - TipRanks
Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial - Investing.com
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis - Investing News Network
Cardiol Therapeutics (NASDAQ: CRDL) reaches 50% MAVERIC Phase III enrollment - Stock Titan
Aug Movers: Can Cardiol Therapeutics Inc maintain its current growth rateJuly 2025 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn
Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long - Yahoo Finance
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
(CRDL) Stock Trading Blueprint (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Reports Financial Challenges Amid Clinical Progress - MSN
What makes Cardiol Therapeutics Inc. stock attractive to growth fundsModel Comparison & lightweight options for faster days - Улправда
Why Cardiol Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 WrapUp & Fast Gain Stock Trading Tips - Улправда
Is Cardiol Therapeutics Inc. stock trading near support levelsAnalyst Downgrade & Advanced Technical Analysis Signals - Улправда
Aug Selloffs: Why Cardiol Therapeutics Inc. stock could benefit from AI revolutionPortfolio Risk Summary & High Conviction Buy Zone Alerts - Улправда
Is Cardiol Therapeutics Inc. (CT9) stock suitable for passive index fundsEarnings Beat & Reliable Breakout Forecasts - ulpravda.ru
Is Cardiol Therapeutics Inc. stock a buy on dipsBond Market & Community Trade Idea Sharing - Улправда
Can Cardiol Therapeutics Inc. (CT9) stock retain market dominanceShort Setup & Stock Portfolio Risk Management - ulpravda.ru
How Cardiol Therapeutics Inc. stock reacts to job market dataBuy Signal & AI Driven Stock Reports - Улправда
How institutional buying supports Cardiol Therapeutics Inc. stockLayoff News & High Return Stock Watch Alerts - Улправда
Is Cardiol Therapeutics Inc. stock attractive for growth ETFs2025 Short Interest & Growth-Oriented Investment Plans - ulpravda.ru
How Cardiol Therapeutics Inc. stock performs in weak economyLong Setup & AI Enhanced Trading Signals - Улправда
(CRDL) Technical Analysis and Trading Signals (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (NASDAQ:CRDL) Trading 1% HigherHere's What Happened - MarketBeat
SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference - Investing News Network
(CRDL) Strategic Market Analysis (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (OTCMKTS:CRTPF) Stock Price Down 1.7% – Should You Sell? - Defense World
Learn to Evaluate (CRDL) using the Charts (CRDL:CA) - Stock Traders Daily
Movement Recap: Why Cardiol Therapeutics Inc stock could benefit from AI revolutionWeekly Risk Report & Risk Adjusted Swing Trade Ideas - moha.gov.vn
Trading (CRDL) With Integrated Risk Controls (CRDL:CA) - Stock Traders Daily
Cardiol TherapeuticsFinancial Details - Crunchbase
HC Wainwright & Co. Reiterates Cardiol Therapeutics (CRDL) Buy Recommendation - MSN
Finanzdaten der Cardiol Therapeutics Inc-Aktie (CRDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):